Reneo Pharmaceuticals (OKUR) Income Statement (2020 - 2025)
Income Statement report data from Mar 31, 2020 to Dec 31, 2025 for Reneo Pharmaceuticals (OKUR).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||||||||||||||||||
Research And Development | 11M (-10.07%) | 12M (-5.47%) | 13M (-3.07%) | 13M | - | 10M (-5.86%) | 11M (+25.44%) | 8.57M | -6.90M | 14M (-5.42%) | 14M (+31.03%) | 11M (+6.08%) | 10M (+4.23%) | 9.94M (+22.26%) | 8.13M (-12.39%) | 9.28M (+30.70%) | 7.10M (-23.82%) | 9.32M (+48.41%) | 6.28M (+14.81%) | 5.47M (+6.84%) | 5.12M (+15.58%) | 4.43M (+57.09%) | 2.82M (-21.23%) | 3.58M |
Selling General And Administrative | 3.41M (-5.01%) | 3.59M (-3.23%) | 3.71M (-7.02%) | 3.99M | - | 1.40M (-61.00%) | 3.59M (+184.92%) | 1.26M | -14.22M | 7.27M (+9.49%) | 6.64M (+29.43%) | 5.13M (+21.85%) | 4.21M (+7.95%) | 3.90M (-9.30%) | 4.30M (+14.97%) | 3.74M (+6.25%) | 3.52M (+2.62%) | 3.43M (+16.27%) | 2.95M (+69.54%) | 1.74M (+53.98%) | 1.13M (+68.66%) | 670K (-23.86%) | 880K (-4.35%) | 920K |
Operating Expenses | 14M (-8.84%) | 16M (-5.02%) | 16M (-4.00%) | 17M | - | 12M (-19.74%) | 14M (+45.88%) | 9.83M | -21.12M | 21M (-0.71%) | 21M (+30.52%) | 16M (+10.71%) | 15M (+5.20%) | 14M (+11.34%) | 12M (-4.53%) | 13M (+22.60%) | 11M (-16.71%) | 13M (+38.14%) | 9.23M (+28.02%) | 7.21M (+15.36%) | 6.25M (+22.55%) | 5.10M (+37.84%) | 3.70M (-17.78%) | 4.50M |
Depreciation And Amortization | 100K (-9.09%) | 110K (-8.33%) | 120K (0.00%) | 120K | - | 110K (-8.33%) | 120K (+9.09%) | 110K (-71.05%) | 380K | - | - | 40K (-42.86%) | 70K | - | - | 20K (0.00%) | 20K (+100.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Operating Income | ||||||||||||||||||||||||
Operating Income | -14.12M (-8.90%) | -15.50M (-5.02%) | -16.32M (-4.00%) | -17.00M | - | -11.51M (-19.74%) | -14.34M (+45.88%) | -9.83M | 21M | -20.89M (-0.71%) | -21.04M (+30.52%) | -16.12M (+10.71%) | -14.56M (+5.20%) | -13.84M (+11.34%) | -12.43M (-4.46%) | -13.01M (+22.50%) | -10.62M (-16.71%) | -12.75M (+38.14%) | -9.23M (+28.02%) | -7.21M (+15.36%) | -6.25M (+22.55%) | -5.10M (+37.84%) | -3.70M (-17.78%) | -4.50M |
Ebit | -14.12M (-8.90%) | -15.50M (-5.02%) | -16.32M (-4.00%) | -17.00M (-2.52%) | -17.44M (+51.52%) | -11.51M (-19.74%) | -14.34M (+45.88%) | -9.83M | 21M | -20.89M (-0.71%) | -21.04M (+30.52%) | -16.12M (+10.71%) | -14.56M (+5.20%) | -13.84M (+11.34%) | -12.43M (-4.46%) | -13.01M (+22.50%) | -10.62M (-16.71%) | -12.75M (+38.14%) | -9.23M (+28.02%) | -7.21M (+15.36%) | -6.25M (+22.55%) | -5.10M (+37.84%) | -3.70M (-17.78%) | -4.50M |
EBITDA | -14.02M (-8.90%) | -15.39M (-5.06%) | -16.21M (-3.97%) | -16.88M (-3.21%) | -17.44M (+52.98%) | -11.40M (-19.89%) | -14.23M (+46.40%) | -9.72M | 18M | -19.20M (-1.69%) | -19.53M (+21.46%) | -16.08M (+4.15%) | -15.44M (+18.68%) | -13.01M (+5.69%) | -12.31M (-5.31%) | -13.00M (+22.53%) | -10.61M (-16.72%) | -12.74M (+38.18%) | -9.22M (+28.06%) | -7.20M (+15.38%) | -6.24M (+22.59%) | -5.09M (+37.94%) | -3.69M (-17.82%) | -4.49M |
Other Income / Expenses | ||||||||||||||||||||||||
Other Non Operating Income | - | - | - | - | - | 970K (-3.00%) | 1.00M (-12.28%) | 1.14M (-79.89%) | 5.67M (+235.50%) | 1.69M (+11.92%) | 1.51M (+48.04%) | 1.02M (-46.03%) | 1.89M (+127.71%) | 830K (+591.67%) | 120K | -20.00K | 50K (+150.00%) | 20K (+100.00%) | 10K | - | - | - | - | - |
Net Income | ||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | -77.39M | - | - | - | -51.95M | - | - | - | -39.77M | - | - | - | -19.46M | - | - | - |
Net Income From Continuing Operations | -13.50M (-8.16%) | -14.70M (-4.48%) | -15.39M (-3.33%) | -15.92M (-8.72%) | -17.44M (+50.87%) | -11.56M (-18.25%) | -14.14M (+48.22%) | -9.54M | 19M | -19.20M (-1.69%) | -19.53M (+29.25%) | -15.11M (+11.10%) | -13.60M (+4.53%) | -13.01M (+5.69%) | -12.31M (-5.60%) | -13.04M (+22.90%) | -10.61M (-16.65%) | -12.73M (+38.07%) | -9.22M (+27.88%) | -7.21M (+15.36%) | -6.25M (+22.79%) | -5.09M (+37.94%) | -3.69M (-16.70%) | -4.43M |
Net Income | -13.50M (-8.16%) | -14.70M (-4.48%) | -15.39M (-3.33%) | -15.92M (-8.72%) | -17.44M (+50.87%) | -11.56M (-18.25%) | -14.14M (+48.22%) | -9.54M | 19M | -19.20M (-1.69%) | -19.53M (+29.25%) | -15.11M (+11.10%) | -13.60M (+4.53%) | -13.01M (+5.69%) | -12.31M (-5.60%) | -13.04M (+22.90%) | -10.61M (-16.65%) | -12.73M (+38.07%) | -9.22M (+27.88%) | -7.21M (+15.36%) | -6.25M (+22.79%) | -5.09M (+37.94%) | -3.69M (-16.70%) | -4.43M |
Comprehensive Income Net Of Tax | - | - | - | - | - | -3.68M (-31.34%) | -5.36M (-36.57%) | -8.45M (-89.07%) | -77.34M (+303.02%) | -19.19M (-1.94%) | -19.57M (+30.03%) | -15.05M (-71.07%) | -52.03M (+294.17%) | -13.20M (+8.11%) | -12.21M (-6.15%) | -13.01M (-67.26%) | -39.74M (+212.42%) | -12.72M (+38.11%) | -9.21M (+27.74%) | -7.21M (-62.97%) | -19.47M (+281.76%) | -5.10M (+38.21%) | -3.69M (-16.52%) | -4.42M |